May Wu, PharmD, BCPS

Doctor of Pharmacy, University of California, San Francisco, San Francisco, CA, 2010

Board certified pharmacotherapy specialist

Intensive Care, Cardiology, Pain and Sedation, Mechanical Support (ECMO and VADs), Pharmacoeconomics

Staveski SL, Wu M, Tesoro TM, Roth SJ, Cisco MJ. Interprofessional Team's Perception of Care Delivery After Implementation of a Pediatric Pain and Sedation Protocol. Crit Care Nurse. 2017 Jun;37(3):66-76.

Hutsell SQ, Wu M, Park KT. Frequency of severe infusion reactions outpatient infusion of infliximab without pre-medications. J Pediatr Gastroenterol Nutr. 2017 Jan 28.

Park KT, Sin A, Wu M, Bass D, Bhattacharya J. Utilization Trends of Anti-TNF Agents and Health Outcomes in Adults and Children with Inflammatory Bowel Diseases: A Single-center Experience. Inflamm Bowel Dis. 2014 Jul;20(7):1242-1249.

Wu M, Sin A, Nishioka F, Park KT. Non-drug costs associated with outpatient infliximab administration in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jun;19(7):1514-7.